$CVS

CVS and AbbVie emerge as recovery opportunities post-market pullback, leveraging diversified operations and immunology momentum respectively, with strong dividend backing investor confidence.

Healthtech startup Bioliberty raises $10.2M Series A led by Scottish National Investment Bank to expand AI capabilities and at-home therapy tracking.

CVS Health's board approved a $0.665 per share quarterly dividend, payable May 4, 2026, reflecting management's confidence in operational stability.

Parkman Healthcare Partners invests $20M in EyePoint Pharmaceuticals as shares surge 93% annually ahead of mid-2026 Phase 3 data for retinal disease treatment DURAVYU.

Glenview Capital establishes $96.45M position in DigitalOcean as the cloud provider reports strong revenue growth and 150% AI service expansion.

CVS and Vertex poised for growth through 2026 via operational improvements and expanded product pipelines. Both companies expected to deliver significant shareholder value.

Salvation Army relocates to Woodbridge Shopping Center, securing 19,000 sq ft at Route 1 and Occoquan Road following Gordon Plaza closure.

Clinical analytics market projected to grow from $33.09B in 2025 to $81.32B by 2030, driven by EHR adoption, AI advances, and value-based care demand.

Kiltearn Partners fully exits Sealed Air stake amid sales headwinds. The divestment of 335,500 shares represents a complete liquidation as Sealed Air faces declining revenues.

Hendricks Commercial Properties sold Marco Island's Island Plaza retail center for $26.6M, realizing a 2.5x equity multiple and 9-13% IRR since its 2013 purchase.